Biotechnology
MBS LABTECH officially launched to sell MBS Capillary Tube designed for biochemistry, immunology, and blood tests in Singapore
SINGAPORE, Nov. 2, 2020 /PRNewswire/ -- MBS LABTECH is delighted to announce the official launch of our website, offering ready access to the MBS Capillary Tube inSingapore and regional markets. The MBS Capillary Tube is designed for simple and precise fingertip blood collection to be used for bi...
2020-11-02 10:00
2050
Investments aim to strengthen capabilities of DuPont(TM) Liveo(TM) healthcare silicone solutions
WILMINGTON, Del., Nov. 2, 2020 /PRNewswire/ -- DuPont™ (NYSE: DD), a globally recognized leader in silicone-based technology and innovations for healthcare, is making significant investments in both capital and resources to strengthen strategic capabilities of its Liveo™ brand healthcare silicone...
2020-11-02 09:00
1936
Samsung Biologics Establishes Partnership with China Biotech GeneQuantum Healthcare to Collaborate on ADC Development
INCHEON, South Korea and SUZHOU, China, Nov. 1, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has entered into a strategic partnership with GeneQuantum Healthcare, a China biotech company, to jointly develop an antibody drug conjugate (ADC) for the treatment of non-small-cell lung carcinoma ...
2020-11-02 08:27
1400
TaiGen Announces FDA Approval of IND for Its Flu Antiviral TG-1000
TAIPEI, Taiwan, Nov. 1, 2020 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen") (Taiwan: 4157) announced today that U.S. Food and Drug Administration ("FDA") has approved the Investigation New Drug (IND) application for TG-1000, a novel treatment for influenza A and B. TG-1000 is a...
2020-11-02 07:30
1283
AVATAMED and Macrogen sign MOU on joint business in personalized precision medicine services in cancer treatment
SINGAPORE, Oct. 30, 2020 /PRNewswire/ -- AVATAMED (www.avatamed.com
2020-10-30 08:00
2846
AGC Biologics and Horizon Therapeutics plc Expand Partnership
Horizon's TEPEZZA® (teprotumumab-trbw) treatment will be produced from AGC Biologics' new facility inBoulder, CO SEATTLE, Oct. 30, 2020 /PRNewswire/ -- AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced that its partnership wit...
2020-10-30 03:17
5038
ZAGENO Acclaimed by Frost & Sullivan for Simplifying the Biotech Purchasing Process with Its Intuitive eCommerce Platform
The platform serves researchers' unique experimental needs by presenting them with the industry's broadest solution portfolio of millions of product SKUs LONDON, Oct. 29, 2020 /PRNewswire/ -- Based on its recent analysis of the global life sciences eCommerce market, Frost & Sullivan recognizesZAG...
2020-10-29 21:00
2188
Hyundai Bioscience: A Korean bio-tech solves the bioavailability issue of Niclosamide
SEOUL, South Korea, Oct. 29, 2020 /PRNewswire/ -- Expectations are increasing as a Korean bio-tech company has succeeded in solving the problem of low absorption which has been one of the biggest obstacles for the repositioning of Niclosamide, an anthelmintic, as the first orally ingested treatme...
2020-10-29 20:00
7380
Complete Data from Connect Biopharma's Phase 1b Study of CBP-201 Demonstrate Rapid, Early and Continuous Improvement in Patient Quality of Life and Atopic Dermatitis (AD) Symptoms
Results from study in adult patients with moderate-to-severe AD presented at EADV Congress SAN DIEGO and TAICANG, SUZHOU, China, Oct. 29, 2020 /PRNewswire/ -- Connect Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of next-generation immune mo...
2020-10-29 19:00
1827
Kintor Pharmaceutical's COVID-19 Clinical Trials for Proxalutamide to expand Patient Enrolment
SUZHOU, China, Oct. 29, 2020 /PRNewswire/ -- Kintor Pharmaceutical Limited (Kintor Pharmaceutical, stock code 9939.HK) is delighted to announced that the clinical trial (ClinicalTrials.gov identifier: NCT04446429, registered by Dr. Andy Goren and Applied Biology) of its anti-androgen treatment Pro...
2020-10-29 18:24
3805
WuXi Biologics and AB2 Bio Announce Collaboration to Accelerate Commercial-Scale Manufacturing of Tadekinig alfa
* Tadekinig alfa is a novel IL-18 binding protein in pivotal Phase 3 testing for orphan disease IL-18 driven monogenic Hemophagocytic Lymphohistiocytosis (HLH) * WuXi Biologics to undertake commercial-scale manufacturing to support U.S. market launch SHANGHAI and LAUSANNE, Switzerland, Oct. 2...
2020-10-29 17:00
2711
Deep Longevity and SquareOne Wellness Partner on Deep Biomarkers of Aging and Longevity
HONG KONG, Oct. 28, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; SEHK:0575.HK) today announced that Deep Longevity, Inc, a company recently acquired by the Group which is a pioneer in deep biomarkers of agin...
2020-10-29 09:57
5274
Asieris' APL-1501 Approved for Phase I Clinical Trial in Australia
SHANGHAI, Oct. 29, 2020 /PRNewswire/ -- Asieris Pharmaceuticals, a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and related diseases, today announced that Australian regulatory authorities have approved it...
2020-10-29 09:35
1970
Samsung Biologics expands global footprint with opening of new San Francisco CDO R&D Center
INCHEON, South Korea and SAN FRANCISCO, Oct. 28, 2020 /PRNewswire/ -- At a virtual ceremony today, Samsung Biologics (KRX: 207940.KS) announced the grand opening of its first US CDO R&D Center inSan Francisco, bringing its contract development services closer to global clients. As the "Next Door ...
2020-10-29 08:38
6608
Gracell Biotechnologies Raises $100 Million in Series C Funding to Advance Next Generation CAR-T Cell Therapies
SHANGHAI and SUZHOU, China, Oct. 28, 2020 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced it has secured$100 million i...
2020-10-28 21:00
2034
MolMed S.p.A Becomes AGC Biologics S.p.A Following the July Acquisition
AGC Biologics Now Provides End-to-End Cell and Gene Therapy CDMO Services SEATTLE, Oct. 28, 2020 /PRNewswire/ -- After its parent company AGC Inc. acquired 100% of the shares of MolMed S.p.A. onSeptember 30, 2020, AGC Biologics announced that MolMed's entity name has been changed to AGC Biologic...
2020-10-28 07:00
2249
Genome & Company announces first patient dosed in Phase 1/1b study of GEN-001, an immuno-oncology microbiome therapeutic, in combination with avelumab
* The first microbiome oncology therapeutic candidate developed by an Asia -based biotech successfully initiatesphase 1/1b clinical trial in the US, six months after its IND went into effect. * The first patient enrolled and treated at OHSU (Oregon Health & Science University Knight Cancer In...
2020-10-27 21:00
1409
I-Mab to Present Preclinical Data of TJ210 at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
SHANGHAI and GAITHERSBURG, Md., Oct. 27, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the Company will present the latest preclinical dat...
2020-10-27 20:05
4620
TVM Capital Life Science Announces Substantially Oversubscribed US$478 Million Final Closing of TVM Life Science Innovation II, largest fund in the firm's history
- The Fund continues the proven "Project Focused Company" investment strategy for early-stage drug development candidates - In addition, the Fund continues to invest in late-stage clinical biopharmaceutical companies, medical device companies and diagnostic companies MUNICH and MONTREAL, Oct. 27...
2020-10-27 20:00
2556
Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study
MELBOURNE, Australia and SAN FRANCISCO, Oct. 26, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced it has commenced enrolling patients with Multiple System Atrophy (MSA) in its bioMUSE Study inthe United States. BioMUSE is a natur...
2020-10-27 10:03
3604
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5216
